FDA Qualified Infectious Disease Product Designations
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Qualified Infectious Disease Product Designation was introduced in 2012 as a provision of the FDA Safety and Innovation Act to encourage development of treatments for serious or life-threatening infections caused by bacteria or fungi.